Resources Contact Us Home
A.sub.3 adenosine receptor agonists

Image Number 11 for United States Patent #5688774.

The present invention provides A.sub.3 selective agonists, particularly, adenine compounds having selected substituents at the 2, 6, and 9 positions, and related substituted compounds, particularly those containing substituents on the benzyl and/or uronamide groups, as well as pharmaceutical compositions containing such compounds. The present invention also provides a method of selectively activating an A.sub.3 adenosine receptor in a mammal, which method comprises acutely or chronically administering to a mammal in need of selective activation of its A.sub.3 adenosine receptor a therapeutically or prophylactically effective amount of a compound which binds with the A.sub.3 receptor so as to stimulate an A.sub.3 receptor-dependent response.

  Recently Added Patents
Molded surface of a concrete product
Selection of hash lookup keys for efficient retrieval
Synergistic fungicidal interactions of 5-fluorocytosine and other fungicides
Stroboscopic image modulation to reduce the visual blur of an object being viewed by an observer experiencing vibration
Digital photographing apparatus
System and method for managing investment funds
Auto-aligning spectroscopy system
  Randomly Featured Patents
Method for assaying primary amines, secondary amines and peptides using fluorogenic derivatization reagents
Eiffel tower wine rack
Starch-based graft polymer, process for its preparation, and use thereof in printing inks and overprint varnishes
Integrated aqua-ammonia chiller/heater
Display screen or portion thereof with a graphical user interface
Tomographic scanning apparatus
Electrical connector for flat cables
Method for forming recess gate of semiconductor device
Simulating an explosion of an improvised explosive device
Process for separating solid asphaltic fraction from hydrocracked petroleum feedstock